VANCOUVER, September 25, 2019 – CANNAMERICA BRANDS CORP. (“CannAmerica Brands” or the “Company”) (CSE: CANA) (OTCQB: CNNXF) is pleased to announce that the nominees set forth in the Company’s management proxy circular dated August 26, 2019, Dan Anglin, Frank Falconer, Nitin Kaushal, Jordan Crockett and Patrick Gray were elected as directors of the Company at the Annual General Meeting of shareholders held today in Vancouver, B.C. (the “Meeting”). At the Meeting the shareholders also approved the appointment of Manning, Elliott, LLP, Chartered Professional Accountants as the auditors of the Company and authorized the Company’s board of directors to fix the auditors remuneration. The shareholders also ratified and approved the Company’s 15% rolling Stock Option Plan.
Following the Meeting, Dan Anglin was appointed President and Chief Executive Officer, Frank Falconer was appointed Chief Commercial Officer, Nitin Kaushal was appointed Chairman of the Board, Paul Ciullo was appointed Chief Financial Officer and Kathy Love was appointed Corporate Secretary.
On Behalf of the Board,
CEO and Director
Grasslands: A Journalism-Minded Agency
About CannAmerica Brands Corp.
CannAmerica is a U.S. marine veteran founded and operated portfolio of cannabis brands with licensing agreements in the states of Colorado, Nevada and Maryland. The Company aims to maximize the value of its brands by employing strong brand management teams, marketing and licensing the brands through various distribution channels, including dispensaries, wholesalers and distributors, in the United States and internationally. The Company’s core strategy is to enhance and monetize the global reach of its existing brands, and to pursue additional strategic acquisitions to grow the scope and diversity of its brand portfolio. For more information, please visit www.cannamericabrands.com.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.